» Articles » PMID: 31036928

UM171 Expands Distinct Types of Myeloid and NK Progenitors from Human Pluripotent Stem Cells

Overview
Journal Sci Rep
Specialty Science
Date 2019 May 1
PMID 31036928
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Scaling up blood cell production from hPSCs is critical to advancing hPSC technologies for blood transfusion, immunotherapy, and transplantation. Here we explored the potential of the HSC agonist pyrimido-indole derivative UM171, to expand hematopoietic progenitors (HPs) derived from hPSCs in chemically defined conditions. We revealed that culture of hPSC-HPs in HSC expansion conditions (SFEM with added TPO, SCF, FLT3L, IL3 and IL6) in the presence of UM171 predominantly expanded HPs with a unique CD34CD41aCD45 phenotype that were enriched in granulocytic progenitors (G-CFCs). In contrast, in lymphoid cultures on OP9-DLL4, in the presence of SCF, FLT3L, and IL7, UM171 selectively expanded CD34CD45CD7 lymphoid progenitors with NK cell potential, and increased NK cell output up to 10-fold. These studies should improve our understanding of the effect of UM171 on de novo generated HPs, and facilitate development of protocols for robust granulocyte and lymphoid cell production from hPSCs, for adoptive immunotherapies.

Citing Articles

Forward programming of hPSCs to neutrophils using chemically defined media.

Hall H, Bao X, Dong C, Lian X Stem Cell Res Ther. 2025; 16(1):32.

PMID: 39894817 PMC: 11789356. DOI: 10.1186/s13287-025-04147-2.


Deciphering the effect of UM171 on human hematopoietic progenitor cell fate through clonal analysis.

Coulombe P, Tomellini E, Chagraoui J, Mayotte N, Sauvageau G Nat Commun. 2025; 16(1):195.

PMID: 39747844 PMC: 11696577. DOI: 10.1038/s41467-024-55225-7.


Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy.

Qiao W, Dong P, Chen H, Zhang J Cells. 2024; 13(23.

PMID: 39682724 PMC: 11640743. DOI: 10.3390/cells13231976.


Feeder-free differentiation of human iPSCs into natural killer cells with cytotoxic potential against malignant brain rhabdoid tumor cells.

Kiran S, Xue Y, Sarker D, Li Y, Sang Q Bioact Mater. 2024; 36:301-316.

PMID: 38496035 PMC: 10940949. DOI: 10.1016/j.bioactmat.2024.02.031.


Improving hematopoietic differentiation from human induced pluripotent stem cells by the modulation of Hippo signaling with a diarylheptanoid derivative.

Thongsa-Ad U, Wongpan A, Wongkummool W, Chaiwijit P, Uppakara K, Chaiyakitpattana G Stem Cell Res Ther. 2024; 15(1):60.

PMID: 38433217 PMC: 10910864. DOI: 10.1186/s13287-024-03686-4.


References
1.
Zonari E, Desantis G, Petrillo C, Boccalatte F, Lidonnici M, Kajaste-Rudnitski A . Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy. Stem Cell Reports. 2017; 8(4):977-990. PMC: 5390102. DOI: 10.1016/j.stemcr.2017.02.010. View

2.
Langmead B, Trapnell C, Pop M, Salzberg S . Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009; 10(3):R25. PMC: 2690996. DOI: 10.1186/gb-2009-10-3-r25. View

3.
Li B, Ruotti V, Stewart R, Thomson J, Dewey C . RNA-Seq gene expression estimation with read mapping uncertainty. Bioinformatics. 2009; 26(4):493-500. PMC: 2820677. DOI: 10.1093/bioinformatics/btp692. View

4.
Paluru P, Hudock K, Cheng X, Mills J, Ying L, Galvao A . The negative impact of Wnt signaling on megakaryocyte and primitive erythroid progenitors derived from human embryonic stem cells. Stem Cell Res. 2014; 12(2):441-51. PMC: 4048963. DOI: 10.1016/j.scr.2013.12.003. View

5.
Vodyanik M, Thomson J, Slukvin I . Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood. 2006; 108(6):2095-105. PMC: 1895535. DOI: 10.1182/blood-2006-02-003327. View